ABOSAcumen Pharmaceuticals, Inc.May 12, 2026Q1 2026
Read transcript →Acumen Pharmaceuticals, Inc. (ABOS) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$2.35
+2.40%
Mkt Cap $152.65M
ABOSAcumen Pharmaceuticals, Inc.May 12, 2026ABOSAcumen Pharmaceuticals, Inc.Mar 26, 2026Q4 2025
Read transcript →ABOSAcumen Pharmaceuticals, Inc.Nov 12, 2025Q3 2025
Read transcript →ABOSAcumen Pharmaceuticals, Inc.Aug 12, 2025Q2 2025
Read transcript →ABOSAcumen Pharmaceuticals, Inc.May 13, 2025Q1 2025
Read transcript →ABOSAcumen Pharmaceuticals, Inc.Mar 27, 2025Q4 2024
Read transcript →ABOSAcumen Pharmaceuticals, Inc.Nov 12, 2024Q3 2024
Read transcript →ABOSAcumen Pharmaceuticals, Inc.Aug 13, 2024Q2 2024
Read transcript →ABOSAcumen Pharmaceuticals, Inc.May 14, 2024Q1 2024
Read transcript →ABOSAcumen Pharmaceuticals, Inc.Mar 26, 2024Q4 2023
Read transcript →ABOSAcumen Pharmaceuticals, Inc.Nov 13, 2023Q3 2023
Read transcript →ABOSAcumen Pharmaceuticals, Inc.Aug 11, 2023Q2 2023
Read transcript →ABOSAcumen Pharmaceuticals, Inc.May 14, 2023Q1 2023
Read transcript →ABOSAcumen Pharmaceuticals, Inc.Mar 27, 2023Q4 2022
Read transcript →ABOSAcumen Pharmaceuticals, Inc.Nov 14, 2022Q3 2022
Read transcript →ABOSAcumen Pharmaceuticals, Inc.Aug 15, 2022Q2 2022
Read transcript →ABOSAcumen Pharmaceuticals, Inc.May 16, 2022Q1 2022
Read transcript →ABOSAcumen Pharmaceuticals, Inc.Mar 28, 2022Q4 2021
Read transcript →